Portal hypertension: Cytokines and endothelins

Hepato-Gastroenterology

Volumn 46, Issue SUPPL. 2, 1999, Pages 1434-1436

  Reichen, J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN;

ANIMAL TISSUE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; SHORT SURVEY;

ANIMALS; CYTOKINES; ENDOTHELINS; HUMANS; HYPERTENSION, PORTAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, ENDOTHELIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033040158     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Vallance P, Moncada, S: Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337:776-778.
2. Elfighi AA, Buttery LDK, Davidson BR, Mathic RT: Nitric oxide expression in human liver cirrhosis. Hepato-Gastroentorol 1999; 46 (Suppl. II); p. 1448. (Abstract)
3. Li XN, Benjamin IS, Alexander B: Further evidence for an hepatic-cardiovascular reflex: demonstrated in a rat model of hepatic circulation in the absence of portal flow in vivo. Hepato-Gastroenterol 1999; 46 (Suppl. II); p. 1448. (Abstract)
4. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146:1220-1234.
5. Wang JH, Redmond HP, Watson RWG, Bouchier-Hayes D: Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis. Am J Physiol 1995; 269:G297-G304.
6. Webber EM, Bruix J, Pierce RH, Fausto N: Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998; 28:1226-1234.
7. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N: Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 1998; 28:959-970.
8. Reichen J, Arts B, Schafroth U, Zimmermann A, Zeltner B, Zysset T: Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study. Gastroenterology 1987; 93:719-726.
9. Gross JB Jr, Reichen J, Zeltner TB, Zimmermann A: The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology 1987; 7:457-463.
10. Khan S, Dodson A, Campbell F, Kawesha A, Al-Ghabra R, Grime JS, Critchley M, Sutton R: Prognostic significance of cytokine expression and hepatocyte volume in cirrhotic portal hypertension. Hepato-Gastroenterol 1999; 46 (Suppl. II): p. 1445. (Abstract)
11. Kaplan LM: Leptin, obesity, and liver disease. Gastroenterol 1998; 115:997-1001.
12. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998; 115:947-953.
13. Potter JJ, Womack L, Mezey E, Anania FA: Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998; 244:178-182.
14. Henriksen JH, Holst JJ, Møller S, Brinch K, Bendtsen F: Increased circulating leptin in cirrhosis: relation to release and disposal. Hepato-Gastroenterol 1999 (Suppl. II); p. 1445. (Abstract)
15. Housset C, Rockey DC, Bissell DM: Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993; 90:9266-9270.
16. Rockey DC: Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun 1995; 207:725-731.
17. Diamantis I, Van de Casteele M, Hurni B, Reichen J: Detection of endothelin-1 and its receptors in rat liver endothelial cells by in situ reverse transcriptase-polymerase chain reaction. J Hepatol 1998; 28:157-160.
18. Mallat A, Fouassier L, Préaux A-M, Serradeil-Le Gal C, Raufaste D, Rosenbaum J, Dhumeaux D, Jouneaux C, Mavier P, Lotersztajn S: Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest 1995; 96:42-49.
19. Gerbes AL, Moller S, Gülberg V, Henriksen JH: Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995; 21:735-739.
20. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P: Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110:534-548.
21. Cahill PA, Hou M-C, Hendrickson R, Wang Y-N, Zhang S, Redmond EM, Sitzmann JV: Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics. Hepatology 1998; 28:396-403.
22. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C, Housset C: Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998; 27:472-480.
23. Eakes AT, Howard KM, Miller JE, Olson MS: Endothelin-1 production by hepatic endothelial cells: characterization and augmentation by endotoxin exposure. Am J Physiol 1997; 272:G605-G611.
24. Ros J, Leivas A, Jiménez W, Morales M, Bosch-Marcé M, Arroyo V, Rivera F, Rodés J: Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. J Hepatol 1997; 26:81-87.
25. Bauer M, Zhang JX, Bauer I, Clemens MG: ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am J Physiol 1994; 267:G143-G149.
26. Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM: Hepatic sinusoidal resistance in portal hypertension: relative roles of endothelin-1 and distortion of hepatic architecture. Hepato-Gastroenterol 1999; 46 (Suppl. II); p. 1446. (Abstract)
27. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec, D: Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterol 1994; 107;1085-1093.
28. Helmy A, Jalan R, Newby DE, Hayes PC, Webb DJ: Evidence for impaired peripheral vascular response to endothelin-1 in patients with pre-ascitic cirrhosis. Hepato-Gastroenterol 1999; 46 (Suppl. II); p. 1446. (Abstract)
29. Sieber CC, Groszmann RJ: Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103:235-239.
30. Higuchi H, Satoh T: Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ETB receptors in isolated perfused rat liver. Eur J Pharmacol 1997; 328:175-182.
31. Shah SHA, Islam MZ, Madhavan KK, Hayes PC, Hadoke PWF: Nitric oxide synthase inhibition does not alter adrenoceptor-mediated contraction of human hepatic arteries in vitro. Hepato-Gastroenterol 1999; 46 (Suppl. II); p. 1447. (Abstract)
32. Fukunaga K, Takada Y, Taniguchi H, Mei G, Seino K, Yuzawa K, Otsuka M, Todoroki T, Goto K, Fukao K: Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation 1999; 67:328-332.
33. Reichen J, Gerbes AL, Stainer MJ, Sägesser H, Clozel M: The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. J Hepatol 1998; 28:1020-1030.
34. Rockey DC Chung JJ: Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996; 98:1381-1388.
35. Wang HG, Shibamoto T, Miyahara T: Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. Am J Physiol 1997; 273:G1036-G1043.
36. Zhang B, Calmus V, Wen L, Sogni P, Lotersztajn S, Houssin D, Weill B: Endothelin-1 induces liver vasoconstriction through both ETA and ETB receptors. J Hepatol 1997; 26:1104-1110.
37. De Gottardi A, Shaw S, Sägesser H, Reichen J: Type A, but not type B endothelin receptor antagonists cause a significant decrease of portal pressure in portal hypertensive rats. Hepato-Gastroenterol 1999; 46 (Suppl. II); p. 1447. (Abstract)
38. Nishida T, Huang T-P, Seiyama A, Hamada E, Kamiike W, Ueshima S, Kazuo H, Matsuda H: Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis. Gastroenterology 1998; 115:412-420.
39. Poo J-L, Jiménez W, Muñoz RM, Bosch-Marcé M, Bordas N, Morales-Ruiz M, Pérez M, Deulofeu R, Solé M, Arroyo V, Rodés J: Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. Gastroenterology 1999; 116:161-167.